Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by The Oncology Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Oncology Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Understanding and Managing Chemotherapy-Induced Peripheral Neuropathy

44:24
 
Share
 

Manage episode 409725310 series 2865758
Content provided by The Oncology Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Oncology Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Welcome to the ninth episode of Supportive Care Matters, a podcast Hosted by Medical Oncologist Professor Bogda Koczwara AM from Adelaide, Australia.

Navigating the silent struggle that many cancer survivors face, this episode promises insights into the lesser-known yet impactful world of chemotherapy-induced peripheral neuropathy (CIPN).
With the expertise of Professor David Goldstein and Associate Professor Susanna Park, this episode sheds light on how CIPN disrupts daily life in ways that go unnoticed by the medical community.
From the nuanced challenges of assessing the severity of this condition to the cognitive toll it takes on patients, Bogda leads a discussion on the critical need for sensitive and precise management strategies that can truly make a difference.
The conversation takes a deep look into the tools and techniques that are transforming how we understand and measure CIPN. Our guests articulate the importance of patient-reported experiences in guiding interventions and the potential benefits of exercise in mitigating neuropathic symptoms. Through this dialogue, we recognise the dedication and collaborative efforts that are pushing the envelope in neuropathy research and care, offering a glimmer of hope for those battling with the long-lasting effects of their cancer treatments.
This episode stands as a testament to the resilience of the human spirit and the ongoing efforts to provide supportive care that truly matters. Subscribe and like to join our mission of bringing these crucial conversations to the forefront and make supportive care matter.
This conversation is produced by The Oncology Network.
TO VIEW SHOW NOTES AND MORE INFORMATION ABOUT SUPPORTIVE CARE MATTERS, HEAD TO WWW.ONCOLOGYNEWS.COM.AU

  continue reading

Chapters

1. Understanding and Managing Chemotherapy-Induced Peripheral Neuropathy (00:00:00)

2. Understanding Chemotherapy-Induced Peripheral Neuropathy (00:00:03)

3. Assessment Tools for CIPN Severity (00:05:47)

4. Clinical Challenges in CIPN Assessment (00:10:55)

5. Addressing Clinician and Patient Reluctance (00:21:55)

6. Comprehensive Approaches to Neuropathy Research (00:26:48)

7. Insights on CIPN Research and Care (00:43:26)

147 episodes

Artwork
iconShare
 
Manage episode 409725310 series 2865758
Content provided by The Oncology Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Oncology Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

Welcome to the ninth episode of Supportive Care Matters, a podcast Hosted by Medical Oncologist Professor Bogda Koczwara AM from Adelaide, Australia.

Navigating the silent struggle that many cancer survivors face, this episode promises insights into the lesser-known yet impactful world of chemotherapy-induced peripheral neuropathy (CIPN).
With the expertise of Professor David Goldstein and Associate Professor Susanna Park, this episode sheds light on how CIPN disrupts daily life in ways that go unnoticed by the medical community.
From the nuanced challenges of assessing the severity of this condition to the cognitive toll it takes on patients, Bogda leads a discussion on the critical need for sensitive and precise management strategies that can truly make a difference.
The conversation takes a deep look into the tools and techniques that are transforming how we understand and measure CIPN. Our guests articulate the importance of patient-reported experiences in guiding interventions and the potential benefits of exercise in mitigating neuropathic symptoms. Through this dialogue, we recognise the dedication and collaborative efforts that are pushing the envelope in neuropathy research and care, offering a glimmer of hope for those battling with the long-lasting effects of their cancer treatments.
This episode stands as a testament to the resilience of the human spirit and the ongoing efforts to provide supportive care that truly matters. Subscribe and like to join our mission of bringing these crucial conversations to the forefront and make supportive care matter.
This conversation is produced by The Oncology Network.
TO VIEW SHOW NOTES AND MORE INFORMATION ABOUT SUPPORTIVE CARE MATTERS, HEAD TO WWW.ONCOLOGYNEWS.COM.AU

  continue reading

Chapters

1. Understanding and Managing Chemotherapy-Induced Peripheral Neuropathy (00:00:00)

2. Understanding Chemotherapy-Induced Peripheral Neuropathy (00:00:03)

3. Assessment Tools for CIPN Severity (00:05:47)

4. Clinical Challenges in CIPN Assessment (00:10:55)

5. Addressing Clinician and Patient Reluctance (00:21:55)

6. Comprehensive Approaches to Neuropathy Research (00:26:48)

7. Insights on CIPN Research and Care (00:43:26)

147 episodes

모든 에피소드

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play